Terns Pharmaceuticals, Inc. (TERN)
52.65
-0.04
(-0.08%)
USD |
NASDAQ |
Apr 17, 16:00
52.62
-0.03
(-0.06%)
After-Hours: 20:00
Terns Pharmaceuticals SG&A Expense (Quarterly) : 8.699M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| Corcept Therapeutics, Inc. | 130.24M |
| Cogent Biosciences, Inc. | 23.93M |
| BioMarin Pharmaceutical, Inc. | 446.21M |
| ADMA Biologics, Inc. | 24.64M |